Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Cellpoint Inc
CLPT | US
9.07
USD-0.31
-3.30%
CLPT | US
Loading StockChartView...
About Cellpoint Inc
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
07/04/2026
Close
9.07
Open
9.26
High
9.28
Low
8.90
ClearPoint Neuro Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB Koninklijke Philips N.V. Blackrock Neurotech and University of California and San Francisco. The company was formerly known as MRI Interventions Inc. and changed its name to ClearPoint Neuro Inc. in February 2020. ClearPoint Neuro Inc. was incorporated in 1998 and is headquartered in Solana Beach California.
View LessCLPT | US
Risk
88.1
Sharpe
-0.30
Luna's Score
37/100
Recommendation
Sell
Luna says (CLPT | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
46.1%1 month
88.1%3 months
94.7%6 months
89.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
10.36
Debt to equity
0.43
Debt to assets
0.26
Ent. to EBITDA
-7.07
Ent. to rev.
11.18
PEG
-
Other Fundamentals
EBITDA
-17.76M
MarketCap
250.29M
MarketCap(USD)
250.29M
Div. yield
-
Op. margin
-60.31
Erngs. growth
-
Rev. growth
32.10
Ret. on equity
-60.40
Short ratio
3.68
Short perc.
2.30
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.30
Range1M
3.31
Range3M
7.99
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.05
Price X volume
7.17M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.07 | 46.09 | Cheaper |
| Ent. to Revenue | 11.18 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 10.36 | 6.21 | Expensive |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 94.70 | 64.12 | Riskier |
| Debt to Equity | 0.43 | -145.53 | Expensive |
| Debt to Assets | 0.26 | 0.35 | Cheaper |
| Market Cap | 250.29M | 9.70B | Emerging |
